# Ultrasound-assisted CNSs Mapping Versus Dual-tracer-guided Sentinel Lymph Node Biopsy

> **NCT04951245** · PHASE3 · COMPLETED · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 330 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** UC group: ultrasound-assisted CNSs guided
- **PROCEDURE:** GC group: CNSs plus ICG dual-tracer-guided

## Key facts

- **NCT ID:** NCT04951245
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-01
- **Primary completion:** 2021-04-30
- **Final completion:** 2021-06-01
- **Target enrollment:** 330 (ACTUAL)
- **Last updated:** 2022-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04951245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04951245, "Ultrasound-assisted CNSs Mapping Versus Dual-tracer-guided Sentinel Lymph Node Biopsy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04951245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*